manufacturing.” BioFactura (a developer and manufacturer of high-value biosimilars and novel drugs) was a key pre-launch testing partner for the Gibco CHOvantage GS Cell Line Development Kit. Lead Cell Line Development Scientist Carson Brackna...
worldwide. RCC is about twice as common in men as in women. Most cases of RCC are discovered incidentally during imaging tests for other abdominal diseases. Approximately 30% of patients with kidney cancer are diagnosed at an advanced stage. About...
The goal of the HEALEY ALS Platform trial is to accelerate the development of potential new ALS therapies. The trial tests and evaluates multiple investigational drugs simultaneously, shares infrastructure across trial sites, and improves start up...
enables more accurate prediction of therapeutic antibody efficacy and safety. Why Antibody Therapies Fail in Late-Stage Testing Antibody therapies work in part by binding to Fcγ receptors, proteins found on immune cells that control key immune...
George, MD, ARUP chief scientific officer and president of ARUP's Innovation Business Unit. "By building and validating tests that are truly commercial-ready, we're not just accelerating innovation, we're ensuring that groundbreaking diagnostics...
and glyco-heterogeneity. Confident proteoform characterization and eXd-enabled glycoproteomics on timsOmni The latest version OmniScape™ 2026b strengthens timsOmni proteoform workflows by integrating the novel OmniWave™ algorithm, which enables...
of 8 GBq 67Cu-SAR-bisPSMA treatment)2, demonstrated that his PSA remains undetectable, with no disease identified on his latest PET conducted 1 month after the administration of the fourth cycle (Feb 2026; Figure 2). Following the first three...
of 2026. SURPASS-IPF will compare deupirfenidone 825 mg TID to pirfenidone 801 mg TID in a head-to-head study powered to test for superiority. Based on feedback from the FDA and other global health authorities, PureTech believes that the results...
for the prevention, diagnosis, care and treatment for people with chronic hepatitis B infection recommend that serological testing for anti-HDV antibodies may be performed for all individuals who are HBsAg positive, as the preferred approach to...
is designed to encourage multiple let-downs per session for effective pumping and maximized milk output. In early product testing, 79% of moms reported improved let-downs and consistently expressed more milk.* "At Lansinoh, we believe moms deserve...
officer of Alamar. "Traditional single-plex assays can measure these biomarkers individually, but require multiple tests to provide a comprehensive view of the disease. With NULISA™ it is now possible to measure multiple Alzheimer's-related...
12.4-15.3) with placebo plus chemotherapy with a HR versus placebo of 0.69 (95% CI: 0.60-0.80).1 Sam Klempner, MD, Gastrointestinal Medical Oncologist, Massachusetts General Hospital, Boston: "Nausea and vomiting are important symptoms that can...
is rapidly absorbed to provide early onset of effect, while SDX is gradually converted to d-MPH in the lower gastrointestinal tract, supporting sustained therapeutic exposure throughout the day. Aizhida was approved by the U.S. FDA in March 2021 as...
Prof. Ivo Boskoski, MD, Christopher McGowan, MD and Abdullah AlMousa, MD on 11 December for a live online session on the latest developments in bariatric endoscopy and GMA with MOVIVA®: Webinar Registration - Zoom...
Healthcare utilization and costs are high, with CMD patients experiencing repeated hospitalizations and multiple coronary tests similar to or exceeding those of patients with obstructive CAD. The A-FLUX Reducer System® is a coronary sinus reducer...
From target discovery to IND submission, Emulate aims to ignite a new era in human health research—one that reduces animal testing, cuts drug development costs, and accelerates the delivery of life-saving treatments. Emulate’s Organ-Chip platforms,...
Marius Pharmaceuticals, Inc. a patient-centric healthcare company committed to advancing innovative therapies for testosterone deficiency, announced that Health Canada has approved KYZATREX® (testosterone undecanoate) CIII capsules. KYZATREX is a...
patients treated with Livdelzi for up to 3 years demonstrated stability or improvement in liver stiffness, with the greatest benefit observed in those at highest risk. This reinforces our belief in Livdelzi’s treatment profile and its potential to...
technology. The M2T™ platform is a completely new approach to cancer immunotherapy and the endorsement from FDA is a testament to its high impact potential.” About Leukogene and M2T™-Platform Leukogene Therapeutics is a preclinical-stage...
progression in cancer Alex Blyth, Chief Executive Officer of LIfT BioSciences, commented: “Being selected to present our latest data underscores growing recognition of our IMAN platform’s potential to transform immuno-oncology. Our findings...